Anhui Medipharm Co., Ltd.
Product Search:
Contact Us

Address: D1702, Anhui Land Square, No.288, Huainin Road, Hefei, Anhui, China.

+86-551-63840330
+86-551-63840550
market@ahmedipharm.com

Your current location:Home >Product  Products

Metronidazole Tablet

Attribute
[Specification] 40+320mg, 8¡¯s/box
[Minimum order quantity] 500000 tablets
[Place Of Origin] China (Mainland)
[Promotional Category] Over The Counter Medicines
[Pharmacological Classification] Anti-amebiasis and anti-trichomoniasis medicines
[Dosage Forms] Tablet
[Appearance] white tablet
[Route of Administration] Oral
[Active Ingredient] Dihydroartemisinin+ Piperaquine Phosphate
[Chemical Name] Dihydroartemisinin+ Piperaquine Phosphate
[Empirical Formula] C15H24O5+C29H32Cl2N6¡¤ 4H3PO4¡¤ 4H2O
[Molecular Weight] 284.35+535.51058
[Validity] Three Years
[Packing] Inner Packing: 40+320mg, 8¡¯s/box
Outer Packing:1000boxes/Carton
Carton Size: 54*45.5*23.5cm3(Only For Reference)

 

 

(Dihydroartemisinin 40mg)
(piperaquine 320mg)
Antimalarial
 
PHARMACOLOGY
DROA-QUINE is a syiieigistic combination of an aitemisinin derivative and a new
bisquiiioline compound;
It is active against the asexual foiins of plasm odium£¬schiqoiits aiid gametocytes. Its action
on scliizonts insures a rapid decrease oi pathogenic parasitaemia which leads to a quick
disappearance of clinical signs; its action on gametocytes prevents coitaminatioii.
The absorption of DROA-QUINE® after oral intake is rapid and complete; it is
extensively distributed in all tissues.
Half life of DHA is very short (around 2 hours) whereas PPQ is long (around 9 days)
 
INDICATIONS
DROA-QIJINE® is indicated for the treatment of all kinds of malaria£¬as long as patients
call take oral medications. It is particularly recommended in the case of multi-i.esistant
Plasmodium lalciparum malaria.
Drug lnteraction:Not clear.
Over Dosage:Not clear
Pregnaney & Lactation and presentation: The pregiiate women with 3 months are prohibited
The later pregnant women nursing mouthers should be taking this medicine under the
physician¡Þs OTitictioiis.
 
ADMINISTOA¡ÞnON AND DOSAGE
0ml administration.
Patient should follow doctor¡Þs instruction. The recommended dosage is the following
table:

 
Adult
Children16£­11
Children11-6
Dav 1
3tabs
2 tabs
1.5 tab
Dav 2
3tabs
2 tabs
1.5 tab
Dav 3
2 tabs
2 tabs
1tab
Total
8 tabs
6 tabs
4 tab

 
ADVERSE EFFECTS
Few cases of adverse effects have been reported after administration of DROA-QUINE®.
Most of tliein are related to PPQ affecting the digestive tract (nausea£¬diarrhea£¬loss of
appetite£¬etc.) Rare reactions have also been reported (rash, pruritus, etc.)
 
CONTRAINDICATIONS
As all new drugs, DROA-QUINE® is not recommended during the first trimester of
pregnancy unless vour doctor considers the risk of the disease to be greater.
A new course DROA-QIUNE® should not be taken within four weeks after the first
treatment.
 
STORAGE
Keep all medicine out of reach of children.
Preserve in tight and lighlproof containers.
Store ill a cool and dry place below 30¡£C
 
Validity: Three Years